An interventional study of Video and Text Reminder in Pre-Eclampsia; Complicating Pregnancy and Gestational Hypertension, sponsored by Ochsner Health System. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-09.
Sponsored by Ochsner Health System · Not applicable, Interventional, and Treatment
Among 228 studies in Pre-Eclampsia with a site in United States — 60 open to participants now, 76 under way, 6 of them phase 3. Pre-Eclampsia · United States.
Among the 228 studies in Pre-Eclampsia with a site in United States, this one is the 25th largest by planned enrollment of the 159 interventional ones that give a count, is one of 13 that started in 2025, is one of 71 with no phase, reaches primary completion later than 19 of the 75 other live ones, and was the 201st registered.
916 studies on the registry are indexed under Pre-Eclampsia; 243 are open to participants now.
Browse Pre-Eclampsia studies →60 of the 228 studies in Pre-Eclampsia with a site in United States are open now. Recruiting first, the newest first:
Mayo Clinic · Sites in United States
University of California, Irvine · Sites in United States
University of Alabama at Birmingham · Sites in United States
Texas Southern University · Sites in United States
Medicines360 · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 162 Pre-Eclampsia studies recruiting now, 81 (50%) set no upper age limit and 80 (49%) stop at 75 or younger; 18 take children under 18; 60 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
228 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 24 · Phase 2 24 · Phase 3 15 · Phase 4 31
First in 2000; this study’s year is marked. 13 started in 2025.
This study's planned enrollment of 296 is above the median of 110 across 480 interventional studies indexed under Pre-Eclampsia.
Median enrollment 89 across the 159 interventional studies, 125 across the 69 observational. Of the 126 that completed or were terminated, 54 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 228 have an industry lead sponsor. The 10 most frequent:
Ochsner Health System is the lead sponsor of 57 studies on the registry; 7 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Ochsner Health System has 1 study filed under Pre-Eclampsia — fewer than ten, so there is no comparison to draw.
26 of the studies in Pre-Eclampsia with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07222852Phase 3Women and Infants Hospital of Rhode IslandCardiovascular Protection After Preeclampsia With Enalapril | 2027-10-15 |
| NCT07293728Oregon Health and Science UniversityA Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia | 2026-12 |
| NCT07356518Wake Forest University Health SciencesTelehealth and Remote Blood Pressure | 2026-12 |
| NCT05676476University of Alabama at BirminghamThe ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy. | 2026-12 |
| NCT05924971MemorialCare Health SystemAspirin for Postpartum Patients With Preeclampsia | 2026-12 |
Among the 228 studies in Pre-Eclampsia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are:
Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes?
Participants will:
View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group will watch an education video, receive text message updates, and have their blood pressure medications titrated to a lower BP goal.
Other: Video · Other: Text Reminder · Other: Blood pressure threshold
This group will receive usual post partum care from their obstetrician
Those in the intervention arm will watch a short educational video.
Those in the intervention group will receive regular text message reminders to check their blood pressures
Those in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards
Engagement
Engagement will be defined by frequency of use: number of remote BP measurements ascertained during the 6 week postpartum period.
Time frame: 6 weeks
Acceptability
Post program survey questions using 5-item Likert response scale at 6 weeks postpartum
Time frame: 6 weeks
Duration of Participation
Duration of participation is defined by the last day of recorded remote BP measurement
Time frame: 6 weeks
Post partum Blood pressure
Proportion of patients with BP \<130/80 at 6 weeks Mean SBP, DBP at 6 weeks, 6 months, 1 year postpartum
Time frame: 1 year
Number of ED visits
Number of ED visits recorded after discharge from her delivery encounter over the following year.
Time frame: 1 year
Severe Maternal Morbidity
Incidence of death, postpartum stroke, congestive heart failure, myocardial infarction, eclampsia
Time frame: 1 year
Number of Inpatient re-admissions
Number of inpatient re-admissions over the following year after discharge from delivery encounter
Time frame: 1 year
Post partum visit follow up
Proportion of 4-6 week postpartum follow up visit attendance with OB provider
Time frame: 6 weeks
Plan to share: Undecided
Started Mar 2025 (actual). Primary completion is estimated for Oct 2026, 18 months after the start.
Of 171 non-industry interventional studies with no phase under Pre-Eclampsia, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 18 months is below that.
Counting every sponsor, half of 176 studies reached it within 24 months; a quarter within 9 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ochsner Health System